印度南部本地治里地区开展淋巴丝虫病消除工作中发病率管理的相关问题研究
Issues in delivering morbidity management for lymphatic filariasis elimination: a study in Pondicherry, South India.
作者信息
Kumari A Krishna, J Yuvaraj, Das L K
机构信息
Vector Control Research Centre, Indian Council of Medical Research, Medical Complex, Indira Nagar, Pondicherry 605 006, India.
出版信息
ScientificWorldJournal. 2012;2012:372618. doi: 10.1100/2012/372618. Epub 2012 Apr 30.
Abstract
Lymphatic filariasis is a vector borne parasitic disease causing long term disability. The Global Programme to Eliminate Lymphatic Filariasis aims to achieve its objective through two strategies; Mass Drug Administration (MDA) to interrupt transmission and Morbidity Management (MM) to manage disability for those already affected. MDA is going on in full swing in endemic areas; but MM is lagging behind. An exploratory study was conducted in Pondicherry through focus group discussions to find out whether there are delivery issues if any, in the MM programme and get suggestions from end users. The study results show that MM has not received the same attention as MDA and there are shortcomings in the delivery mechanism of the programme. The importance of these findings are discussed and suggestions given for improving the programme.
摘要
淋巴丝虫病是一种由媒介传播的寄生虫病，可导致长期残疾。全球消除淋巴丝虫病规划旨在通过两种策略实现其目标；大规模药物治疗（MDA）以阻断传播，以及发病管理（MM）以管理已受影响者的残疾状况。MDA在流行地区正在全面展开；但MM却滞后了。在本地治里通过焦点小组讨论进行了一项探索性研究，以查明MM项目中是否存在交付问题（如有），并征求终端用户的建议。研究结果表明，MM没有得到与MDA相同的关注，并且该项目的交付机制存在缺陷。讨论了这些发现的重要性，并给出了改进该项目的建议。
相似文献
1
Issues in delivering morbidity management for lymphatic filariasis elimination: a study in Pondicherry, South India.印度南部本地治里地区开展淋巴丝虫病消除工作中发病率管理的相关问题研究
ScientificWorldJournal. 2012;2012:372618. doi: 10.1100/2012/372618. Epub 2012 Apr 30.
2
Information technology in morbidity management of human lymphatic filariasis-A promising tool in global programme for elimination of lymphatic filariasis.信息技术在人类淋巴丝虫病发病管理中的应用——全球消除淋巴丝虫病计划中的一项有前景的工具。
J Vector Borne Dis. 2018 Jan-Mar;55(1):20-25. doi: 10.4103/0972-9062.234622.
3
Mass drug administration to eliminate lymphatic filariasis in India.在印度开展群体服药以消除淋巴丝虫病。
Trends Parasitol. 2004 Nov;20(11):499-502. doi: 10.1016/j.pt.2004.08.010.
4
Evaluation of lymphatic filariasis in endemic area of Brazil where mass drug administration is not required.评价巴西流行区的淋巴丝虫病，该地无需开展大规模药物治疗。
Pathog Glob Health. 2019 May;113(3):143-148. doi: 10.1080/20477724.2019.1623546. Epub 2019 May 29.
5
Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study.加强群体药物给药实施对于在印度消除淋巴丝虫病是必要的：一项评估研究。
J Vector Borne Dis. 2008 Dec;45(4):313-20.
6
How Thailand eliminated lymphatic filariasis as a public health problem.泰国如何消除淋巴丝虫病这一公共卫生问题。
Infect Dis Poverty. 2019 May 27;8(1):38. doi: 10.1186/s40249-019-0549-1.
7
Diethylcarbamazine citrate-fortified salt for lymphatic filariasis elimination in India.枸橼酸乙胺嗪强化盐在印度消除淋巴丝虫病的应用。
Indian J Med Res. 2022 Mar;155(3&4):347-355. doi: 10.4103/ijmr.ijmr_171_22.
8
Elimination of lymphatic filariasis in west African urban areas: is implementation of mass drug administration necessary?在西非城区消除淋巴丝虫病：是否有必要实施大规模药物治疗？
Lancet Infect Dis. 2018 Jun;18(6):e214-e220. doi: 10.1016/S1473-3099(18)30069-0. Epub 2018 Feb 3.
9
Elimination of lymphatic filariasis: do we have the drugs to complete the job?消除淋巴丝虫病：我们有完成这项工作的药物吗？
Curr Opin Infect Dis. 2010 Dec;23(6):617-20. doi: 10.1097/QCO.0b013e32833fdee5.
引用本文的文献
1
Social and healthcare-seeking experiences of people affected with lymphedema in Bangladesh.孟加拉国淋巴水肿患者的社会及就医经历
PLoS Negl Trop Dis. 2025 Aug 12;19(8):e0013384. doi: 10.1371/journal.pntd.0013384. eCollection 2025 Aug.
2
Global insights can accelerate India's journey towards the elimination of lymphatic filariasis as a public health problem.全球视野能够加速印度消除淋巴丝虫病这一公共卫生问题的进程。
BMJ Glob Health. 2025 Jul 10;10(7):e018851. doi: 10.1136/bmjgh-2025-018851.
3
Unveiling the gendered abyss: exploring the case of women with lymphatic filariasis and the path to inclusive care in India.揭开性别差异的深渊：探索印度淋巴丝虫病女性患者的情况及包容性护理之路。
Int J Equity Health. 2025 Feb 17;24(1):47. doi: 10.1186/s12939-025-02397-3.
4
Assessment of the Impact of Morbidity Management and Disability Prevention for Lymphatic Filariasis on the Disease Burden in Villupuram District of Tamil Nadu, India.印度泰米尔纳德邦维鲁布尔姆区淋巴丝虫病发病管理与残疾预防对疾病负担影响的评估
Indian J Community Med. 2021 Oct-Dec;46(4):657-661. doi: 10.4103/ijcm.IJCM_12_21. Epub 2021 Dec 8.
5
Exploring determinants of hydrocele surgery coverage related to Lymphatic Filariasis in Nepal: An implementation research study.探索尼泊尔与淋巴丝虫病相关的鞘膜积液手术覆盖率的决定因素：一项实施研究
PLoS One. 2021 Feb 26;16(2):e0244664. doi: 10.1371/journal.pone.0244664. eCollection 2021.
6
Health beliefs and health seeking behavior towards lymphatic filariasis morbidity management and disability prevention services in Luangwa District, Zambia: Community and provider perspectives.赞比亚卢安瓜地区淋巴丝虫病发病率管理和残疾预防服务的健康信念和健康寻求行为：社区和提供者的观点。
PLoS Negl Trop Dis. 2021 Feb 22;15(2):e0009075. doi: 10.1371/journal.pntd.0009075. eCollection 2021 Feb.
7
The role of non-governmental development organizations in the implementation of lymphatic filariasis programmes.非政府发展组织在实施淋巴丝虫病规划方面的作用。
Int Health. 2020 Dec 22;13(Suppl 1):S44-S47. doi: 10.1093/inthealth/ihaa049.
8
Morbidity management and disability prevention for lymphatic filariasis in Sri Lanka: Current status and future prospects.斯里兰卡淋巴丝虫病的发病率管理和残疾预防：现状和未来展望。
PLoS Negl Trop Dis. 2018 May 10;12(5):e0006472. doi: 10.1371/journal.pntd.0006472. eCollection 2018 May.
9
Lymphatic pathology in asymptomatic and symptomatic children with Wuchereria bancrofti infection in children from Odisha, India and its reversal with DEC and albendazole treatment.印度奥里萨邦感染班氏吴策线虫的无症状和有症状儿童的淋巴病理学及其通过乙胺嗪和阿苯达唑治疗的逆转情况。
PLoS Negl Trop Dis. 2017 Oct 23;11(10):e0005631. doi: 10.1371/journal.pntd.0005631. eCollection 2017 Oct.
10
Antifilarial and Antibiotic Activities of Methanolic Extracts of Melaleuca cajuputi Flowers.白千层花甲醇提取物的抗丝虫和抗生素活性
Korean J Parasitol. 2016 Jun;54(3):273-80. doi: 10.3347/kjp.2016.54.3.273. Epub 2016 Jun 30.
本文引用的文献
1
Lymphatic Filariasis in India : Problems, Challenges and New Initiatives.印度的淋巴丝虫病：问题、挑战与新举措
Med J Armed Forces India. 2006 Oct;62(4):359-62. doi: 10.1016/S0377-1237(06)80109-7. Epub 2011 Jul 21.
2
Efficacy of home-based lymphoedema management in reducing acute attacks in subjects with lymphatic filariasis in Burkina Faso.家庭为基础的淋巴水肿管理在减少布基纳法索淋巴丝虫病患者急性发作中的疗效。
Acta Trop. 2011 Sep;120 Suppl 1:S55-61. doi: 10.1016/j.actatropica.2011.03.007. Epub 2011 Apr 4.
3
Lymphatic filariasis in Andhra Pradesh Paper Mill Colony, Rajahmundry, India after nine rounds of MDA programme.印度拉贾蒙德里安德拉邦造纸厂聚居区在开展九轮大规模药物治疗项目后的淋巴丝虫病情况
J Vector Borne Dis. 2010 Mar;47(1):55-7.
4
Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study.加强群体药物给药实施对于在印度消除淋巴丝虫病是必要的：一项评估研究。
J Vector Borne Dis. 2008 Dec;45(4):313-20.
5
6
Neglected patients with a neglected disease? A qualitative study of lymphatic filariasis.被忽视的疾病患者被忽视了吗？淋巴丝虫病的定性研究。
PLoS Negl Trop Dis. 2007 Nov 21;1(2):e128. doi: 10.1371/journal.pntd.0000128.
7
Clinicians' practices related to management of filarial adenolymphangitis and lymphoedema in Orissa, India.印度奥里萨邦临床医生对丝虫性腺淋巴管炎和淋巴水肿的管理实践。
Acta Trop. 2007 Jun;102(3):159-64. doi: 10.1016/j.actatropica.2007.04.014. Epub 2007 Apr 29.
8
Lymphoedema and its management in cases of lymphatic filariasis: the current situation in three suburbs of Matara, Sri Lanka, before the introduction of a morbidity-control programme.淋巴丝虫病病例中的淋巴水肿及其管理：在实施发病率控制计划之前，斯里兰卡马特勒三个郊区的现状。
Ann Trop Med Parasitol. 2005 Jul;99(5):501-10. doi: 10.1179/136485905X46450.
9
10
Lymphoedema: Pathophysiology and management in resource-poor settings - relevance for lymphatic filariasis control programmes.淋巴水肿：资源匮乏地区的病理生理学与管理——对淋巴丝虫病控制项目的意义
Filaria J. 2003 Mar 12;2(1):4. doi: 10.1186/1475-2883-2-4.
Zotero 插件